» Articles » PMID: 28396545

Salicylidene Acylhydrazides and Hydroxyquinolines Act As Inhibitors of Type Three Secretion Systems in Pseudomonas Aeruginosa by Distinct Mechanisms

Overview
Specialty Pharmacology
Date 2017 Apr 12
PMID 28396545
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Type 3 secretion systems (T3SSs) are major virulence factors in Gram-negative bacteria. expresses two T3SSs, namely, an injectisome (iT3SS) translocating effector proteins in the host cell cytosol and a flagellum (fT3SS) ensuring bacterial motility. Inhibiting these systems is an appealing therapeutic strategy for acute infections. This study examines the protective effects of the salicylidene acylhydrazide INP0341 and of the hydroxyquinoline INP1750 (previously described as T3SS inhibitors in other species) toward cytotoxic effects of Both compounds reduced cell necrosis and inflammasome activation induced by reference strains or clinical isolates expressing T3SS toxins or only the translocation apparatus. INP0341 inhibited iT3SS transcriptional activation, including in strains with constitutive iT3SS expression, and reduced the total expression of toxins, suggesting it targets iT3SS gene transcription. INP1750 inhibited toxin secretion and flagellar motility and impaired the activity of the YscN ATPase from (homologous to the ATPase present in the basal body of iT3SS and fT3SS), suggesting that it rather targets a T3SS core constituent with high homology among iT3SS and fT3SS. This mode of action is similar to that previously described for INP1855, another hydroxyquinoline, against Thus, although acting by different mechanisms, INP0341 and INP1750 appear as useful inhibitors of the virulence of Hydroxyquinolines may have a broader spectrum of activity by the fact they act upon two virulence factors (iT3SS and fT3SS).

Citing Articles

Type III Secretion System in Intestinal Pathogens and Metabolic Diseases.

Zhou L, Zhang Y, Wu S, Kuang Y, Jiang P, Zhu X J Diabetes Res. 2024; 2024:4864639.

PMID: 39544522 PMC: 11561183. DOI: 10.1155/2024/4864639.


Using next generation antimicrobials to target the mechanisms of infection.

Gadar K, McCarthy R NPJ Antimicrob Resist. 2024; 1(1):11.

PMID: 38686217 PMC: 11057201. DOI: 10.1038/s44259-023-00011-6.


Pseudomonas aeruginosa from river water: antimicrobial resistance, virulence and molecular typing.

Rojo-Bezares B, Casado C, Ceniceros T, Lopez M, Chichon G, Lozano C FEMS Microbiol Ecol. 2024; 100(5).

PMID: 38444209 PMC: 11004943. DOI: 10.1093/femsec/fiae028.


Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses.

Wood S, Goldufsky J, Seu M, Dorafshar A, Shafikhani S Cells. 2023; 12(1).

PMID: 36611990 PMC: 9818787. DOI: 10.3390/cells12010195.


Genetic and Environmental Investigation of a Novel Phenylamino Acetamide Inhibitor of the Pseudomonas aeruginosa Type III Secretion System.

Fang L, Banerjee B, Yuan X, Zeng Q, Liang C, Chen X Appl Environ Microbiol. 2022; 89(1):e0175222.

PMID: 36519869 PMC: 9888221. DOI: 10.1128/aem.01752-22.


References
1.
Miao E, Mao D, Yudkovsky N, Bonneau R, Lorang C, Warren S . Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A. 2010; 107(7):3076-80. PMC: 2840275. DOI: 10.1073/pnas.0913087107. View

2.
Bailey L, Gylfe A, Sundin C, Muschiol S, Elofsson M, Nordstrom P . Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett. 2007; 581(4):587-95. DOI: 10.1016/j.febslet.2007.01.013. View

3.
Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K . Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980; 26(2):171-6. DOI: 10.1002/ijc.2910260208. View

4.
Lomovskaya O, Watkins W . Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem. 2001; 8(14):1699-711. DOI: 10.2174/0929867013371743. View

5.
Yahr T, Wolfgang M . Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system. Mol Microbiol. 2006; 62(3):631-40. DOI: 10.1111/j.1365-2958.2006.05412.x. View